Paradigm lost: How parasite control may alter pattern and process in human helminthiases

Trends in Parasitology

Volumn 28, Issue 4, 2012, Pages 161-171

  Basáñez, María Gloria ^a   French, Michael D ^a   Walker, Martin ^a   Churcher, Thomas S ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; DIETHYLCARBAMAZINE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G4; IVERMECTIN; MEBENDAZOLE; PRAZIQUANTEL; PYRANTEL;

ANCYLOSTOMA DUODENALE; ASCARIASIS; ASCARIS LUMBRICOIDES; CHEMOTHERAPY; CYSTICERCOSIS; DENSITY; ENDEMIC DISEASE; HELMINTH; HELMINTHIASIS; HOST PARASITE INTERACTION; IMMUNE RESPONSE; LIFE CYCLE; LIFESPAN; MORTALITY; NECATOR AMERICANUS; NONHUMAN; ONCHOCERCIASIS; PARASITE CONTROL; PARASITE DEVELOPMENT; PARASITE PREVALENCE; PARASITE SURVIVAL; PARASITE TRANSMISSION; REVIEW; SCHISTOSOMIASIS; TRICHURIS;

AGE FACTORS; ANIMALS; ANTHELMINTICS; HELMINTHIASIS; HELMINTHS; HOST-PARASITE INTERACTIONS; HUMANS; POPULATION DENSITY; PREVALENCE;

VERMES;

EID: 84858996949     PISSN: 14714922     EISSN: 14715007     Source Type: Journal    
DOI: 10.1016/j.pt.2012.02.004     Document Type: Review

References (90)

1. Anderson R.M., May R.M. Helminth infections of humans: mathematical models, population dynamics, and control. Adv. Parasitol. 1985, 24:1-101.
2. Churcher T.S., et al. Mass treatment of parasitic disease: implications for the spread of anthelmintic resistance. Antimicrobial Resistance - Beyond the Breakpoint, Issues in Infectious Diseases Series 2010, Vol. 6:120-137. Karger.
3. Prichard, R.K. et al. (2012) A research agenda for helminth diseases of humans: intervention for control and elimination. PLoS Negl. Trop. Dis. doi:10.1371/journal.pntd.0001549.
4. Anderson R.M., May R.M. Herd immunity to helminth infection and implications for parasite control. Nature 1985, 315:493-496.
5. Woolhouse M.E. Patterns in parasite epidemiology: the peak shift. Parasitol. Today 1998, 14:428-434.
6. Stothard J.R., et al. The epidemiology and control of urinary schistosomiasis and soil-transmitted helminthiasis in schoolchildren on Unguja Island, Zanzibar. Trans. R. Soc. Trop. Med. Hyg. 2009, 103:1031-1044.
7. Raso G., et al. Multiple parasite infections and their relationship to self-reported morbidity in a community of rural Côte d'Ivoire. Int. J. Epidemiol. 2004, 33:1092-1102.
8. Fenton A., et al. Detecting interspecific macroparasite interactions from ecological data: patterns and process. Ecol. Lett. 2010, 13:606-615.
9. Brooker S., et al. Epidemiology of Plasmodium-helminth co-infection in Africa: populations at risk, potential impact on anemia, and prospects for combining control. Am. J. Trop. Med. Hyg. 2007, 77:88-98.
10. Pion S.D.S., et al. Co-infection with Onchocerca volvulus and Loa loa microfilariae in central Cameroon: are these two species interacting?. Parasitology 2006, 132:843-854.
11. Pullan R., Brooker S. The health impact of polyparasitism in humans: are we under-estimating the burden of parasitic diseases?. Parasitology 2008, 135:783-794.
12. Pullan R.L., et al. Human helminth co-infection: analysis of spatial patterns and risk factors in a Brazilian community. PLoS Negl. Trop. Dis. 2008, 2:e352.
13. Fenton A. Worms and germs: the population dynamic consequences of microparasite-macroparasite co-infection. Parasitology 2008, 135:1545-1560.
14. Brooker S., et al. Human hookworm infection in the 21st century. Adv. Parasitol. 2004, 58:197-288.
15. Bottomley C., et al. Population biology of multispecies helminth infection: interspecific interactions and parasite distribution. Parasitology 2005, 131:417-433.
16. Hall A., et al. Intensity of reinfection with Ascaris lumbricoides and its implications for parasite control. Lancet 1992, 339:1253-1257.
17. Geary T.G., et al. Unresolved issues in anthelmintic pharmacology for helminthiases of humans. Int. J. Parasitol. 2010, 40:1-13.
18. Michael E., Bundy D.A.P. Density dependence in establishment, growth and worm fecundity in intestinal helminthiasis: the population biology of Trichuris muris (Nematoda) infection in CBA/Ca mice. Parasitology 1989, 98:451-458.
19. Basáñez M.G., et al. Transmission intensity and the patterns of Onchocerca volvulus infection in human communities. Am. J. Trop. Med. Hyg. 2002, 67:669-679.
20. Duerr H.P., et al. Density-dependent parasite establishment suggests infection-associated immunosuppression as an important mechanism for parasite density regulation in onchocerciasis. Trans. R. Soc. Trop. Med. Hyg. 2003, 97:242-250.
21. Medley G.F., Anderson R.M. Density-dependent fecundity in Schistosoma mansoni infections in man. Trans. R. Soc. Trop. Med. Hyg. 1985, 79:532-534.
22. Paterson S., Viney M.E. Host immune responses are necessary for density dependence in nematode infections. Parasitology 2002, 125:283-292.
23. Kotze A.C., Kopp S.R. The potential impact of density dependent fecundity on the use of the faecal egg count reduction test for detecting drug resistance in human hookworms. PLoS Negl. Trop. Dis. 2008, 2:e297.
24. Walker M., et al. Density-dependent effects on the weight of female Ascaris lumbricoides infections of humans and its impact on patterns of egg production. Parasit. Vectors 2009, 2:11.
25. Basáñez M.G., et al. Onchocerca-Simulium interactions and the population and evolutionary biology of Onchocerca volvulus. Adv. Parasitol. 2009, 68:263-313.
26. Little M.P., et al. Association between microfilarial load and excess mortality in onchocerciasis: an epidemiological study. Lancet 2004, 363:1514-1521.
27. Churcher T.S., et al. Density dependence and overdispersion in the transmission of helminth parasites. Parasitology 2005, 131:121-132.
28. Duerr H.P., et al. Determinants of the eradicability of filarial infections: a conceptual approach. Trends Parasitol. 2005, 21:88-96.
29. Churcher T.S., et al. Density dependence and the control of helminth parasites. J. Anim. Ecol. 2006, 75:1313-1320.
30. Dietz K. Density dependence in parasite transmission dynamics. Parasitol. Today 1988, 4:91-97.
31. Churcher T.S., Basáñez M.G. Density dependence and the spread of anthelmintic resistance. Evolution 2008, 62:528-537.
32. Macdonald G. The dynamics of helminth infections, with special reference to schistosomes. Trans. R. Soc. Trop. Med. Hyg. 1965, 59:489-506.
33. May R.M. Togetherness among schistosomes: its effects on the dynamics of the infection. Math. Biosci. 1977, 35:301-343.
34. World Health Organization Control of Lymphatic Filariasis in China 2003, World Health Organization.
35. Nicolas L. New tools for diagnosis and monitoring of Bancroftian filariasis parasitism: the Polynesian experience. Parasitol. Today 1997, 13:370-375.
36. Elkins D.B., Haswell-Elkins M. The weight/length profiles of Ascaris lumbricoides within a human community before mass treatment and following reinfection. Parasitology 1989, 99:293-299.
37. Diawara L., et al. Feasibility of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: first evidence from studies in Mali and Senegal. PLoS Negl. Trop. Dis. 2009, 3:e497.
38. Gambhir M., et al. Geographic and ecologic heterogeneity in elimination thresholds for the major vector-borne helminthic disease, lymphatic filariasis. BMC Biol. 2010, 8:22.
39. Duerr H.P., et al. Control of onchocerciasis in Africa: threshold shifts, breakpoints and rules for elimination. Int. J. Parasitol. 2011, 41:581-589.
40. Crofton H.D. A model of host-parasite relationships. Parasitology 1971, 63:343-364.
41. Anderson R.M. Determinants of infection in human schistosomiasis. Baillière's Clinical Tropical Medicine and Communicable Diseases 1987, Vol. 2. Baillière Tindall, 279-300.
42. Guyatt H.L., et al. The relationship between the frequency distribution of Ascaris lumbricoides and the prevalence and intensity of infection in human communities. Parasitology 1990, 101:139-143.
43. Brooker S., et al. Evaluating the epidemiological impact of national control programmes for helminths. Trends Parasitol. 2004, 20:537-545.
44. Holland C.V., et al. The epidemiology of Ascaris lumbricoides and other soil-transmitted helminths in primary school children from Ile-Ife, Nigeria. Parasitology 1989, 99:275-285.
45. French M.D., et al. Observed reductions in Schistosoma mansoni transmission from large-scale administration of praziquantel in Uganda: a mathematical modelling study. PLoS Negl. Trop. Dis. 2010, 4:e897.
46. Plaisier A.P., et al. ONCHOSIM: a model and computer simulation program for the transmission and control of onchocerciasis. Comput. Methods Programs Biomed. 1990, 31:43-56.
47. Wilson K., et al. Heterogeneities in macroparasite infections: patterns and processes. The Ecology of Wildlife Diseases 2002, 6-44. Oxford University Press. P.J. Hudson (Ed.).
48. Filipe J.A.N., et al. Human infection patterns and heterogeneous exposure in river blindness. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:15265-15270.
49. Padmasiri E.A., et al. Controlling lymphatic filariasis and soil-transmitted helminthiasis together in South Asia: opportunities and challenges. Trans. R. Soc. Trop. Med. Hyg. 2006, 100:807-810.
50. Massa K., et al. The combined effect of the Lymphatic Filariasis Elimination Programme and the Schistosomiasis and Soil-transmitted Helminthiasis Control Programme on soil-transmitted helminthiasis in schoolchildren in Tanzania. Trans. R. Soc. Trop. Med. Hyg. 2009, 103:25-30.
51. Koukounari A., et al. Integrated monitoring and evaluation and environmental risk factors for urogenital schistosomiasis and active trachoma in Burkina Faso before preventative chemotherapy using sentinel sites. BMC Infect. Dis. 2011, 11:191.
52. Zhang Y., et al. Parasitological impact of 2-year preventive chemotherapy on schistosomiasis and soil-transmitted helminthiasis in Uganda. BMC Med. 2007, 5:27.
53. Dunne D., Mountford A. Resistance to infection in human and animal models. Schistosomiasis 2001, 133-212. Imperial College Press. A.A.F. Mahmoud (Ed.).
54. Woolhouse M.E.J., et al. Acquired immunity and epidemiology of Schistosoma haematobium. Nature 1991, 351:757-758.
55. Fulford A.J.C., et al. On the use of age-intensity data to detect immunity to parasitic infections, with special reference to Schistosoma mansoni in Kenya. Parasitology 1992, 105:219-227.
56. Michael E., Bundy D.A.P. Herd immunity to filarial infection is a function of vector biting rate. Proc. R. Soc. Lond. B 1998, 265:855-860.
57. Basáñez M.G., Boussinesq M. Population biology of human onchocerciasis. Philos. Trans. R. Soc. Lond. B 1999, 354:809-826.
58. Pinot de Moira A., et al. Analysis of complex patterns of human exposure and immunity to Schistosomiasis mansoni: the influence of age, sex, ethnicity and IgE. PLoS Negl. Trop. Dis. 2010, 4:e820.
59. Stolk W.A., et al. Meta-analysis of age-prevalence patterns in lymphatic filariasis: no decline in microfilaraemia prevalence in older age groups as predicted by models with acquired immunity. Parasitology 2004, 129:605-612.
60. Kightlinger L.K., et al. The epidemiology of Ascaris lumbricoides, Trichuris trichiura, and hookworm in children in the Ranomafana rainforest, Madagascar. J. Parasitol. 1995, 81:159-169.
61. Hall A., et al. The distribution of Ascaris lumbricoides in human hosts: a study of 1765 people in Bangladesh. Trans. R. Soc. Trop. Med. Hyg. 1999, 9:503-510.
62. Fulford A.J.C., et al. Puberty and age-related changes in susceptibility to schistosome infection. Parasitol. Today 1998, 14:23-26.
63. Kurtis J.D., et al. Pubertal development predicts resistance to infection and reinfection with Schistosoma japonicum. Clin. Infect. Dis. 2006, 42:1692-1698.
64. Woolhouse M.E., Hagan P. Seeking the ghost of worms past. Nat. Med. 1999, 5:1225-1227.
65. Fulford A.J., et al. A statistical approach to schistosome population dynamics and estimation of the life-span of Schistosoma mansoni in man. Parasitology 1995, 110:307-316.
66. Mutapi F., et al. Praziquantel treatment of individuals exposed to Schistosoma haematobium enhances serological recognition of defined parasite antigens. J. Infect. Dis. 2005, 192:1108-1118.
67. Mai C.S., et al. Onchocerca volvulus-specific antibody and cytokine responses in onchocerciasis patients after 16 years of repeated ivermectin therapy. Clin. Exp. Immunol. 2007, 147:504-512.
68. McCarthy, J. et al. (2012) A research agenda for helminth diseases of humans: diagnostics for control and elimination programmes. PLoS Negl. Trop. Dis. doi:10.1371/journal.pntd.0001601.
69. World Health Organization Accelerating Work to Overcome the Global Impact of Neglected Tropical Diseases: A Roadmap for Implementation (Executive summary) 2012, World Health Organization. http://whqlibdoc.who.int/hq/2012/WHO_HTM_NTD_2012.1_eng.pdf.
70. Harhay M.O., et al. Diagnostics are central for a truly holistic approach against intestinal parasitic diseases. Int. J. Infect. Dis. 2011, 15:e76-e77.
71. Bergquist R., et al. Diagnostic dilemmas in helminthology: what tools to use and when?. Trends Parasitol. 2009, 25:151-156.
72. Basáñez, M.G. et al. (2012) A research agenda for helminth diseases of humans: modelling for control and elimination. PLoS Negl. Trop. Dis. doi:10.1371/journal.pntd.0001548.
73. Stepek G., et al. Human gastrointestinal nematode infections: Are new control methods required?. Int. J. Exp. Pathol. 2006, 87:325-341.
74. Keiser J., Utzinger J. Efficacy of current drugs against soil-transmitted helminth infections: systematic review and meta-analysis. J. Am. Med. Assoc. 2008, 229:1937-1948.
75. Belizario V.Y., et al. A comparison of the efficacy of single doses of albendazole, ivermectin, and diethylcarbamazine alone or in combinations against Ascaris and Trichuris spp. Bull. World Health Organ. 2003, 81:35-42.
76. Mani T.R., et al. Efficacy of co-administration of albendazole and diethylcarbamazine against geohelminthiases: a study from South India. Trop. Med. Int. Health 2002, 7:541-548.
77. Utzinger J., Keiser J. Schistosomiasis and soil-transmitted helminthiasis: common drugs for treatment and control. Expert Opin. Pharmacother. 2004, 5:263-285.
78. Stothard J.R., et al. Closing the praziquantel treatment gap: new steps in epidemiological monitoring and control of schistosomiasis in African infants and preschool-aged children. Parasitology 2011, 138:1593-1606.
79. Awadzi K., et al. The co-administration of ivermectin and albendazole - safety, pharmacokinetics and efficacy against Onchocerca volvulus. Ann. Trop. Med. Parasitol. 2003, 97:165-178.
80. Awadzi K., et al. The chemotherapy of onchocerciasis. XIV. Studies with mebendazole citrate. Trop. Med. Parasitol. 1990, 41:383-386.
81. Basáñez M.G., et al. Effect of single-dose ivermectin on Onchocerca volvulus: a systematic review and meta-analysis. Lancet Infect. Dis. 2008, 8:310-322.
82. Awadzi K., et al. The chemotherapy of onchocerciasis XX: ivermectin in combination with albendazole. Trop. Med. Parasitol. 1995, 46:213-220.
83. Awadzi K., et al. The chemotherapy of onchocerciasis. XI. A double-blind comparative study of ivermectin, diethylcarbamazine and placebo in human onchocerciasis in northern Ghana. Ann. Trop. Med. Parasitol. 1986, 80:433-442.
84. Diallo S., et al. A double-blind comparison of the efficacy and safety of ivermectin and diethylcarbamazine in a placebo controlled study of Senegalese patients with onchocerciasis. Trans. R. Soc. Trop. Med. Hyg. 1986, 80:927-934.
85. Tisch D.J., et al. Mass chemotherapy options to control lymphatic filariasis: a systematic review. Lancet Infect. Dis. 2005, 5:514-523.
86. Michael E., et al. Mathematical modelling and the control of lymphatic filariasis. Lancet Infect. Dis. 2004, 4:223-234.
87. Cao W.C., et al. Ivermectin for the chemotherapy of bancroftian filariasis: a meta-analysis of the effect of single treatment. Trop. Med. Int. Health 1997, 2:393-403.
88. Stolk W.A., et al. Effects of ivermectin and diethylcarbamazine on microfilariae and overall microfilaria production in bancroftian filariasis. Am. J. Trop. Med. Hyg. 2005, 73:881-887.
89. De Kraker M.E., et al. Model-based analysis of trial data: microfilaria and worm-productivity loss after diethylcarbamazine-albendazole or ivermectin-albendazole combination therapy against Wuchereria bancrofti. Trop. Med. Int. Health 2006, 11:718-728.
90. Kihara, J.H. et al. (2012) A four-year follow-up of school children after mass-treatment for schistosomiasis and soil-transmitted helminths in Mwea, Central Kenya. Afr. J. Health Sci. (in press).